Here, we employ inducible AKT-isoform-specific shRNAs and CRISPR/Cas9-mediated gene editing in human melanoma cell lines to outline the role of AKT2 in the metastatic cell seeding of oncogenic BRAF-driven PTEN-null melanoma through the enhancement of cell migration and invasiveness. The gene discussed is AKT1; the disease is melanoma.